Risk of Heart Disease in Patients With Amputation: A Nationwide Cohort Study in South Korea
Journal of the American Heart Association
Abstract
Background
Amputation confers disabilities upon patients and is linked to substantial morbidity and death attributed to heart disease. While some studies have focused on traumatic amputees in veterans, few studies have focused on traumatic amputees within the general population. Therefore, the present study aimed to assess the risk of heart disease in patients with traumatic amputation with disability within the general population using a large‐scale nationwide population‐based cohort.
Methods and Results
We used data from the Korean National Health Insurance System. A total of 22 950 participants with amputation were selected with 1:3 age, sex‐matched controls between 2010 and 2018. We used Cox proportional hazard models to calculate the risk of myocardial infarction, heart failure, and atrial fibrillation among amputees. Participants with amputation had a higher risk of myocardial infarction (adjusted hazard ratio [aHR], 1.30 [95% CI, 1.14–1.47]), heart failure (aHR, 1.27 [95% CI, 1.17–1.38]), and atrial fibrillation (aHR, 1.17 [95% CI, 1.03–1.33]). The risks of myocardial infarction and heart failure were further increased by the presence of disability (aHR, 1.43 [95% CI, 1.04–1.95]; and aHR, 1.38 [95% CI, 1.13–1.67], respectively).
Conclusions
We demonstrate an increased risk of myocardial infarction, heart failure, and atrial fibrillation among individuals with amputation, and the risk further increased in those with disabilities. Clinicians should pay attention to the increased risk for heart disease in patients with amputation.
Nonstandard Abbreviations and Acronyms
- NDR
- National Disability Registry
- NHIS
- National Health Insurance System
Clinical Perspective
What Is New?
•
The population of patients with traumatic amputation is at increased risk of myocardial infarction, heart failure, and atrial fibrillation.
•
Disability after amputation further increases the risk of heart disease.
•
Amputation itself, rather than vascular causes, can contribute to developing heart disease.
What Are the Clinical Implications?
•
This study highlights the importance of preventing heart disease in the population of patients with traumatic amputation.
•
Clinicians should closely monitor patients after amputation and provide timely intervention.
•
Implementing rehabilitation programs for patients with amputation with disabilities is essential to reduce their risk of developing heart disease.
Amputation is the surgical removal of a limb or extremity that is performed under various medical conditions to sustain life. Amputation can leave patients with disabilities and is associated with significant death and morbidity.1, 2 One of the major causes of increased mortality risk among patients with amputation is heart disease.3, 4 Growing evidence has revealed the association between amputation and various heart diseases.
Increased cardiac‐related death in amputation has been investigated in previous cohort studies conducted in the United States. A cohort study of American Indians with diabetes demonstrated that 134 patients with lower extremity amputation showed 90% increased cardiovascular disease mortality risk compared with 1974 patients without amputation.5 A retrospective study on combat veterans with lower extremity amputation demonstrated an association between amputation and cardiovascular disease risk factors, including mean arterial pressure, triglycerides, and high‐density lipoprotein cholesterol.6 The study further showed that individuals with bilateral lower limb amputation had a 2.25‐fold higher risk of metabolic syndrome compared with those without amputation. In addition, a small cohort study with 162 participants with amputation reported a 3.78‐fold risk for major cardiovascular events in people with transfemoral amputation compared with 1:10 age, sex, and residency duration matched controls.7 These studies assert that amputation is attributable to not only increasing mortality rates, but also to increasing the incidence of heart disease.
Most studies of patients with amputation have been conducted in the West and have focused on patients with amputations due to nontraumatic causes (Table S1). This is because in the United States, vascular diseases such as peripheral artery disease or as a result of diabetic comorbidity account for up to 81.9% of major causes of amputation.8, 9 Therefore, interpretation of the association between amputation due to vascular cause and heart disease is based on patients who are already at risk for cardiovascular disease, so caution should be exercised in interpreting whether amputation itself increases the risk of heart disease. Traumatic amputation is the next most common cause, accounting for about 16.4% of patients with amputation,9 but most studies that focused on subjects with traumatic amputation were conducted with small sample sizes and were limited to lower extremity amputation because the participants were mainly veterans.6, 10 In contrast, according to the fact sheet of amputees in Korea, upper limb amputation is more prevalent than lower limb amputation. As reported in 2020, traumatic injury due to accident is the most common cause of amputation, accounting for 92.9% of 122 240 patients with upper limb amputation and 76.3% of 49 516 patients with lower limb amputation.11 Therefore, it is possible to conduct research on patients with amputation due to traumatic causes in Korea using subjects from the general population instead of being limited to a specific group of veterans or patients with lower limb amputation, which will be helpful to better understand the cardiovascular effects of amputation itself. With this strength, we conducted the present study to investigate the risk of various heart diseases, including myocardial infarction (MI), heart failure (HF), and atrial fibrillation (AF), among patients with traumatic amputation using a nationwide, large, population‐based cohort with consideration of the disability status of patients with amputation.
METHODS
Data Availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Data Source and Study Setting
This study was based on data provided by the National Health Insurance System (NHIS) in Korea. The NHIS provides mandatory universal health insurance to ≈97% of the Korean population, and the Medical Aid program provides insurance to the remaining 3% of the population with the lowest income. The NHIS recommends general health screening for all insured individuals conducted at least biennially for the prevention and early detection of diseases, including cardiovascular disease.12 The NHIS contains information on medical and social history, anthropometric measurements, and laboratory tests. In addition, the NHIS retains a medical treatment database that is based on medical expense claims from medical service providers. Therefore, the NHIS incorporates an extensive health information data set of the entire Korean population.
Study Population
We identified 59 392 participants with amputation that occurred between 2010 and 2018. The definition of amputation was based on the International Classification of Diseases, Tenth Revision (ICD‐10) codes as follows: Z89 (acquired absence of limb), S48 (traumatic amputation of shoulder joint), S58 (traumatic amputation of forearm), S68 (traumatic amputation of wrist, finger), S78 (traumatic amputation of hip), S88 (traumatic amputation of knee), and S98 (traumatic amputation of ankle, toe). We included participants who underwent health screening within 2 years before the index date (n=27 832). We then excluded participants who were aged <20 years (n=22), and those with a history of the following medical conditions: (1) diabetes with complications including ulcer of lower limb (ICD‐10 codes E10.6, E11.6, E12.6, E13.6, E14.6, L97, or E11.621), (2) thromboangiitis obliterans (ICD‐10 I73.1), (3) arterial embolism and thrombosis (ICD‐10 I74), (3) MI (ICD‐10 I21 or I22 with ≥1 hospitalizations), (4) HF (ICD‐10 I50 with ≥1 hospitalizations), or (5) AF (ICD‐10 I48 with ≥1 hospitalizations or at least 2 outpatient visits). Participants with missing information were excluded (n=1038), which resulted in a total of 22 950 participants with amputation.
To select the control group, we conducted 1:3 age and sex matching serially year by year, ensuring that participants with amputation diagnosed in a specific year were matched to control participants who were alive during the same year. Each control participant was assigned an index date corresponding to the date of amputation for their matched participant with amputation. After applying the same exclusion criteria, a total of 76 645 matched controls were included in the analysis. The selection process for the study population is illustrated in Figure 1.

Figure 1. Study population flowchart.
This study was approved by the Institutional Review Board of Samsung Medical Center (Institutional Review Board File No. 2020‐12‐068). The review board waived written informed consent because the data are public and anonymized under confidentiality guidelines.
Severity of Disability Due to Amputation
To consider the effect of disability, we used disability grade registered in the NDR (National Disability Registry) of the Ministry of Health and Welfare.13 In Korea, people with a disability are registered to obtain social benefit from the government. Specialist physicians document the disability diagnosis with physical examination and radiographs, and submission of validated documents is required. The degree of disability ranges from grade 1, the most severe, to grade 6, the mildest (Tables S2 and S3). In general, the severity of disability varies depending on the site of proximal amputation. For example, grade 1 disability from upper extremity amputation is defined by amputation above the wrist joint of both arms, whereas grade 6 disability is defined by amputation of one thumb above the interphalangeal joint. In this study, those who were registered in the NDR within 1 year from the index date were classified as the disability group, and they were further divided into mild to moderate (grade 4–6) and severe (grade 1–3) disability groups.
Study Outcomes and Follow‐Up
The study outcomes were newly diagnosed MI, HF, or AF on the basis of ICD‐10 codes during follow‐up. MI was defined as a claim with ICD‐10 I21 or I22 codes with ≥1 hospitalizations.14, 15, 16 HF was defined as a claim with an I50 code with ≥1 hospitalizations.17 AF was defined as a claim with an I48 code with ≥1 hospitalizations or at least 2 visits to an outpatient clinic.18 The cohort was followed from the index date to the first occurrence of MI, HF, AF, death, or until the last follow‐up date (December 31, 2019), whichever came first.
Covariates
Sociodemographic information including age, sex, income level, and residential area were provided by the NHIS database. Alcohol consumption was divided into none, mild to moderate (<30 g of alcohol/day), and heavy (≥30 g/day) drinker. Smoking status was divided into never, former smoker, and current smoker. Regular physical activity was defined as either moderate physical activity for >30 minutes per session ≥5 days per week or vigorous physical activity for >20 minutes per session ≥3 days per week. Comorbidities were identified on the basis of claims data before the screening date and health screening results. Hypertension was defined as a claim with I10, I11, I12, I13, or I15 codes and antihypertensive medication, or systolic/diastolic blood pressure≥140/90 mm Hg. Type 2 diabetes was defined as a claim with E11, E12, E13, or E14 codes and antidiabetic medication prescription or fasting glucose level≥126 mg/dL. Dyslipidemia was defined as a claim with an E78 code and lipid‐lowering medications, or total cholesterol level≥240 mg/dL. To assess overall comorbidity load, we used the primary care equivalent of the Charlson comorbidity index based on the ICD‐10 code.19
Statistical Analysis
Descriptive analysis of study subjects was performed to compare the basic characteristics of survivors with amputation and their matched controls. Cox proportional hazards regression analysis was performed to calculate hazard ratio (HR) and 95% CI for study outcomes among participants with amputation. Each study outcome event was followed, and analysis was performed independently. Model 1 was adjusted for age, sex, and Charlson comorbidity index. Model 2 was further adjusted for socioeconomic status (income level and place of residence), health behaviors (alcohol consumption, smoking, and regular physical activity), and comorbidities (hypertension, type 2 diabetes, and dyslipidemia). In addition, we used a 1‐year lag sensitivity analysis to mitigate surveillance bias, where individuals with amputation are more likely to undergo medical examinations compared with those without amputation. This analysis excluded participants with end point occurrences within 1 year of follow‐up, and the lag was calculated using a time‐series analysis technique.20 The operational definition of sensitivity analysis is illustrated in Figure S1.
Statistical analyses were performed using SAS version 9.4 (SAS Institute Inc., Cary, NC), and a P value <0.05 was considered statistically significant.
RESULTS
Baseline Characteristics
Baseline characteristics of the study population are presented in Table 1. In participants with amputation, the mean age was 53.5 (SD, 12) years, and 76.5% were men. Compared with controls, participants with amputation had lower income and were more likely to live in a rural area, be heavy drinkers, be current smokers, and were less likely to engage in physical activity. They had more comorbidities, including hypertension and type 2 diabetes, and higher Charlson comorbidity index scores.
Variables | Matched controls (N=76 645) | Individuals with amputation (N=22 950) | P value |
---|---|---|---|
Age, y | 52.8±11.8 | 53.5±12.0 | <0.001 |
Sex, male | 60 046 (78.3) | 17 551 (76.5) | <0.001 |
Income (Medicaid+lowest 20%) | 13 219 (17.3) | 4313 (18.8) | <0.001 |
Place of residence (urban) | 35 088 (45.8) | 7810 (34.0) | <0.001 |
Alcohol consumption | <0.001 | ||
None | 32 940 (43.0) | 10 152 (44.6) | |
Mild to moderate | 35 620 (46.5) | 9717 (42.4) | |
Heavy | 8085 (10.6) | 4027 (17.6) | |
Smoking status | <0.001 | ||
Never | 33 833 (44.1) | 10 183 (44.4) | |
Former | 19 125 (25.0) | 4859 (21.2) | |
Current | 23 687 (30.7) | 7908 (34.5) | |
Regular physical activity | 16 852 (22.0) | 4027 (17.6) | <0.001 |
Body mass index, kg/m2 | 24.2±3.1 | 24.1±3.1 | <0.001 |
Systolic blood pressure, mm Hg | 124.1±14.3 | 124.1±14.6 | 0.674 |
Diastolic blood pressure, mm Hg | 77.5±9.8 | 77.4±10.0 | 0.168 |
Fasting glucose, mg/dL | 101.0±24.5 | 101.6±26.9 | <0.001 |
Total cholesterol, mg/dL | 197.4±37.1 | 196.0±37.4 | <0.001 |
Comorbidities | |||
Hypertension | 24 298 (31.7) | 7414 (32.3) | 0.085 |
Type 2 diabetes | 8944 (11.7) | 2825 (12.3) | 0.008 |
Dyslipidemia | 19 383 (25.3) | 5631 (24.5) | 0.021 |
Charlson comorbidity index | 1.1±1.5 | 1.4±1.6 | <0.001 |
Data are presented as number (%) or mean±SD.
Risk of MI, HF, and AF Among Participants With Amputation
During a mean follow‐up period of 5.2 (SD, 2.5) years, there were 335 incident MI cases (2.8 per 1000 person‐years), 781 incident HF cases (6.5 per 1000 person‐years), and 338 incident AF cases (2.8 per 1000 person‐years) observed among participants with amputation (Table 2). Kaplan–Meier curves show that the incidence probabilities of MI, HF, and AF in participants with amputation was higher than controls (log‐rank P<0.001; Figure 2). Compared with controls, participants with amputation had a higher risk of MI (adjusted HR [aHR], 1.30 [95% CI, 1.14–1.47]), HF (aHR, 1.27 [95% CI, 1.17–1.38]), and AF (aHR, 1.17 [95% CI, 1.03–1.33]). The risks were further increased by the presence of disability; MI (aHR, 1.43 [95% CI, 1.04–1.95]) and HF (aHR, 1.38 [95% CI, 1.13–1.67]). In particular, those with severe disability had the highest risk of HF (aHR, 2.34 [95% CI, 1.62–3.38]). The consistent results were noted with a 1‐year lag period (Table 3).
N | Myocardial infarction | Heart failure | Atrial fibrillation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Cases/IR | Model 1 | Model 2 | Cases/IR | Model 1 | Model 2 | Cases/IR | Model 1 | Model 2 | ||
Matched controls | 76 645 | 844/2.0 | 1 (Ref.) | 1 (Ref.) | 1939/4.7 | 1 (Ref.) | 1 (Ref.) | 949/2.3 | 1 (Ref.) | 1 (Ref.) |
Individuals with amputation | 22 950 | 335/2.8 | 1.29 (1.14–1.47)* | 1.30 (1.14–1.47)* | 781/6.5 | 1.30 (1.20–1.42)* | 1.27 (1.17–1.38)* | 338/2.8 | 1.17 (1.03–1.32)* | 1.17 (1.03–1.33)* |
By presence of disability | ||||||||||
No disability | 21 135 | 293/2.6 | 1.3 (1.14–1.48)* | 1.28 (1.12–1.46)* | 677/6.1 | 1.29 (1.18–1.40)* | 1.25 (1.15–1.37)* | 293/2.6 | 1.15 (1.01–1.31)* | 1.15 (1.01–1.31)* |
Disability | 1815 | 42/4.2 | 2.03 (1.49–2.77)* | 1.43 (1.04–1.95)* | 104/10.4 | 1.43 (1.17–1.74)* | 1.38 (1.13–1.69)* | 45/4.5 | 1.29 (0.95–1.73) | 1.30 (0.97–1.76) |
By severity of disability | ||||||||||
Mild to moderate | 1477 | 33/4.0 | 1.36 (0.96–1.92) | 1.35 (0.95–1.92) | 75/9.2 | 1.23 (0.98–1.55) | 1.20 (0.95–1.51) | 36/4.4 | 1.24 (0.89–1.73) | 1.26 (0.90–1.76) |
Severe | 338 | 9/5.0 | 1.76 (0.91–3.40) | 1.81 (0.94–3.49) | 29/16.3 | 2.40 (1.66–3.46)* | 2.34 (1.62–3.38)* | 9/5.0 | 1.50 (0.78–2.89) | 1.52 (0.79–2.94) |
Model 1: adjusted for age, sex, and Charlson comorbidity index. Model 2: model 1+adjusted for socioeconomic position (income level and place of residence), smoking, alcohol consumption, physical activity, and comorbidities (hypertension, type 2 diabetes, and dyslipidemia). IR indicates incidence rate (numbers of cases per 1000 person‐years).
*
Significant at p<0.05.

Figure 2. Kaplan–Meier survival analysis for the incidence of cardiovascular disease in participants with amputation compared with matched controls.
A, Myocardial infarction; (B) heart failure; (C) atrial fibrillation.
N | Myocardial infarction | Heart failure | Atrial fibrillation | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Cases/IR | Model 1 | Model 2 | Cases/IR | Model 1 | Model 2 | Cases/IR | Model 1 | Model 2 | ||
Matched controls | 76 236 | 724/2.15 | 1 (Ref.) | 1 (Ref.) | 1753/5.2 | 1 (Ref.) | 1 (Ref.) | 810/2.4 | 1 (Ref.) | 1 (Ref.) |
Individuals with amputation | 22 701 | 272/2.8 | 1.24 (1.08–1.43)* | 1.23 (1.07–1.42)* | 685/7.0 | 1.28 (1.17–1.40)* | 1.25 (1.14–1.37)* | 283/2.9 | 1.16 (1.01–1.33)* | 1.17 (1.02–1.34)* |
By presence of disability | ||||||||||
No disability | 20 920 | 241/2.7 | 1.24 (1.07–1.43)* | 1.23 (1.06–1.43)* | 598/6.7 | 1.27 (1.16–1.39)* | 1.24 (1.13–1.36)* | 244/2.7 | 1.14 (0.99–1.31) | 1.15 (0.99–1.32) |
Disability | 1781 | 31/3.8 | 1.24 (0.07–2.02)* | 1.24 (0.86–1.78)* | 87/10.7 | 1.33 (1.07–1.65)* | 1.30 (1.04–1.61)* | 39/4.8 | 1.32 (0.96–1.82) | 1.36 (0.98–1.87) |
By severity of disability | ||||||||||
Mild to moderate | 1457 | 26/3.9 | 1.25 (0.84–1.85) | 1.24 (0.84–1.84) | 67/10.0 | 1.23 (0.96–1.57) | 1.19 (0.93–1.53) | 31/4.6 | 1.25 (0.88–1.80) | 1.29 (0.90–1.85) |
Severe | 324 | 5/3.4 | 1.19 (0.49–2.86) | 1.21 (0.50–2.92) | 20/14.0 | 1.88 (1.21–2.92)* | 1.83 (1.18–2.84)* | 8/5.6 | 1.65 (0.82–3.31) | 1.71 (0.85–3.43) |
The sensitivity analysis excluded participants with the occurrence of end points within 1 y of follow‐up. Model 1: adjusted for age, sex, and Charlson comorbidity index. Model 2: model 1+adjusted for socioeconomic position (income level and place of residence), smoking, alcohol consumption, physical activity, and comorbidities (hypertension, type 2 diabetes, and dyslipidemia). IR indicates incidence rate (numbers of cases per 1000 person‐years).
*
Significant at p<0.05.
DISCUSSION
This nationwide, large, population‐based cohort study to assess the risk of heart disease among patients with traumatic amputation with disabilities found that individuals with amputation are at higher risk of heart disease than patients without amputation, and the risk further increased with an increase in amputation severity, especially for HF.
Amputation and MI
Our study showed an increased risk for developing MI in patients with amputation. This result is concurrent with prior studies in which patients with amputation had greater risk for developing MI compared with patients without amputation.7, 21, 22 A possible explanation for the increased incidence of MI after amputation is due to the increased prevalence of traditional cardiovascular disease risk factors such as obesity, physical inactivity,23 hypertension,24 dyslipidemia,25 and insulin resistance26 among amputees. Amputation is also known to alter the structure of endothelial cells within coronary arteries, rendering them more susceptible to ischemia due to hemodynamic changes and arterial remodeling.27 In terms of hemodynamic consequences, amputation increases both shear stress and circumferential arterial wall stress, thereby promoting a thrombotic and inflammatory environment in the vascular system.28 Furthermore, shear stress has been demonstrated to affect the production of prostacyclin and plasminogen activators, which can be factors contributing to atherosclerosis.29, 30, 31 Atherosclerotic change was observed in an in vitro study with mice that underwent ligation of the right carotid artery,32 suggesting that vessel ligation due to amputation can result in arterial remodeling that leads to atherosclerosis. In addition, amputees exhibit increased levels of blood coagulating factors such as fibrinopeptide A and factor VII, and their higher coagulability may contribute to increased atherosclerosis and ischemic vascular injury.25 Overall, altered hemodynamic changes, hyperinsulinemia, and increased sympathetic and coagulation activity act as complex factors to explain increased risk for MI among individuals with amputation.
Amputation and HF
Our findings demonstrated that patients with amputation are at a greater risk of developing HF when compared with matched controls. A retrospective cohort study conducted in Scotland reported that the risk of HF was 1.95‐fold (95% CI, 1.14–3.33) higher in patients with incident lower extremity amputation,33 which is consistent with the degree of risk in our study. Considering that the most common cause of HF is ischemic heart disease and the risk of MI increases in patients with amputation as mentioned above, the risk of developing HF of ischemic origin may be increased. In addition, changes in cardiac function that occur after amputation can increase the incidence of HF.26, 34 For example, an increase in resting heart rate and blood pressure due to a decrease in functional capacity and an inability to increase stroke volume in work or stress may contribute to the development of HF.35, 36, 37, 38 An additional explanation for the increased incidence of HF after amputation is an increased prevalence of traditional cardiovascular disease risk factors, including increased insulin resistance,24, 25 arterial stiffness,35, 39 and endothelial dysfunction.40
Amputation and AF
In this study, amputation increased the incidence of AF, albeit to a lesser extent compared with MI and HF. As we show in the baseline characteristics, patients with amputation are prone to have more AF risk factors such as old age, alcohol consumption, and hypertension than the general population without amputation. In addition, physical or psychological stress may contribute to AF development.41, 42, 43, 44 Previous studies reported that cardiovascular remolding after amputation such as increased arterial stiffness, thickened intima media, and higher pulse wave velocity, could result in AF development.45
Patients With Amputation With Disabilities and Heart Disease
In our study, the risk of MI and HF was found to be even higher in patients with amputation with disabilities, and the risk of HF further increased by 2.34‐fold in those with severe disabilities. Prior research has suggested that higher levels of amputations lead to greater hemodynamic changes and cardiovascular responses,46, 47 supporting our result showing an increased risk of heart disease as the site of amputation becomes more proximal (Table S4). In a study involving patients with traumatic lower limb amputation,47 patients with transfemoral amputation exhibited higher energy expenditure and more significant changes in the cardiovascular system compared with patients with transtibial amputation. In particular, patients with transfemoral amputation demonstrated an increase in oxygen consumption, which may indicate a reduction in cardiorespiratory fitness and could be a potential explanation for the increased risk of heart disease48 in patients with amputation with severe disabilities. Although there are not many comparative studies on heart disease risk specifically in patients with disabilities and amputation, psychological factors related to disability could be involved. Previous studies25, 41, 42, 43, 44, 49 reported that psychological stress may increase sympathetic tone, blood coagulability, and shear stress force, which are changes contributing to an increased risk of heart disease. In addition, as the degree of disability becomes more severe in patients with amputation, they may become socially isolated and encounter environmental barriers that lead to a decrease in physical activity, an increase in obesity, and changes in lifestyle such as smoking and drinking alcohol, which are the factors that also contribute to an increased risk of heart disease.50, 51 However, before and after comparison of health behaviors between the patients with amputation and matched controls revealed minimal differences in changes of smoking, drinking, and physical activity level between the 2 groups (Table S5). This suggests that, rather than traditional risk factors, hemodynamic changes resulting from amputation play a major role in the increased risk observed in patients with amputation.
Clinical Implications
Overall, our results highlighted the importance of preventing heart disease in patients with amputation, especially those with severe disabilities. It is notable that many cardiovascular disease risk factors can be modified through treatment.6 Therefore, clinicians should closely monitor patients after amputation and provide them with timely interventions such as relevant medications. It is also important to consider promptly implementing rehabilitation programs for patients with amputation with disabilities to improve their physical and mental well‐being and reduce their risk of developing heart disease.
Limitations
Despite the strengths and the clinical implications, our study has some limitations. Since we used claims data, determining the precise cause of amputation beyond the information provided by ICD‐10 codes poses a challenge. Nevertheless, we meticulously eliminated potential vascular causes of amputation through the use of ICD‐10 codes. Moreover, our results show that patients with amputation with severe disabilities were at higher risk for only HF with statistical significance, despite the fact that MI and AF also showed increased risk in comparison with those with mild disabilities. This could be due to the smaller number of cases for MI and AF that were claimed as ICD‐10 codes. Due to limited access to medical care for individuals with amputations, there is a possibility that the risk of heart disease may have been underestimated. Finally, generalization of our results requires caution due to the fact that the data primarily consisted of Korean participants.
CONCLUSIONS
Individuals with acquired amputation are at higher risk of developing heart disease than those without amputation, and the risk increases as the severity of disability increases. Our study suggests that timely preventive measures against cardiovascular disease should be taken for individuals who have undergone amputation.
Sources of Funding
None.
Disclosures
None.
Footnotes
This manuscript was sent to Tiffany M. Powell‐Wiley, MD, MPH, Associate Editor, for review by expert referees, editorial decision, and final disposition.
Supplemental Material is available at Supplemental Material
For Sources of Funding and Disclosures, see page 8.
Supplemental Material
Tables S1–S5
Figure S1
References 5,52–54
- Download
- 362.48 KB
References
1.
Fortington LV, Geertzen JH, van Netten JJ, Postema K, Rommers GM, Dijkstra PU. Short and long term mortality rates after a lower limb amputation. Eur J Vasc Endovasc Surg. 2013;46:124–131.
2.
Jones WS, Patel MR, Dai D, Vemulapalli S, Subherwal S, Stafford J, Peterson ED. High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease. Am Heart J. 2013;165:809–815.
3.
Kaptein S, Geertzen JHB, Dijkstra PU. Association between cardiovascular diseases and mobility in persons with lower limb amputation: a systematic review. Disabil Rehabil. 2018;40:883–888.
4.
Nallegowda M, Lee E, Brandstater M, Kartono AB, Kumar G, Foster GP. Amputation and cardiac comorbidity: analysis of severity of cardiac risk. PM R. 2012;4:657–666.
5.
Resnick HE, Carter EA, Lindsay R, Henly SJ, Ness FK, Welty TK, Lee ET, Howard BV. Relation of lower‐extremity amputation to all‐cause and cardiovascular disease mortality in American Indians: the strong heart study. Diabetes Care. 2004;27:1286–1293.
6.
Bhatnagar V, Richard E, Melcer T, Walker J, Galarneau M. Retrospective study of cardiovascular disease risk factors among a cohort of combat veterans with lower limb amputation. Vasc Health Risk Manag. 2019;15:409–418.
7.
Mundell BF, Luetmer MT, Kremers HM, Visscher S, Hoppe KM, Kaufman KR. The risk of major cardiovascular events for adults with transfemoral amputation. J Neuroeng Rehabil. 2018;15:58.
8.
Pasquina PF, Miller M, Carvalho AJ, Corcoran M, Vandersea J, Johnson E, Chen YT. Special considerations for multiple limb amputation. Curr Phys Med Rehabil Rep. 2014;2:273–289.
9.
Dillingham TR, Pezzin LE, MacKenzie EJ. Limb amputation and limb deficiency: epidemiology and recent trends in the United States. South Med J. 2002;95:875–883.
10.
Mayfield JA, Reiber GE, Maynard C, Czerniecki JM, Caps MT, Sangeorzan BJ. Survival following lower‐limb amputation in a veteran population. J Rehabil Res Dev. 2001;38:341–345.
11.
Bok SK, Song Y. Fact sheet of amputee 10‐year trends in Korea: from 2011 to 2020. Ann Rehabil Med. 2022;46:221–227.
12.
Shin DW, Cho J, Park JH, Cho B. National General Health Screening Program in Korea: history, current status, and future direction. Precis Future Med. 2022;6:9–31.
13.
Kim M, Jung W, Kim SY, Park JH, Shin DW. The Korea National Disability Registration System. Epidemiol Health. 2023;45:e2023053.
14.
Jeong SM, Jeon KH, Shin DW, Han K, Kim D, Park SH, Cho MH, Lee CM, Nam KW, Lee SP. Smoking cessation, but not reduction, reduces cardiovascular disease incidence. Eur Heart J. 2021;42:4141–4153.
15.
Cho IY, Yoo JE, Han K, Kim D, Jeong SM, Hwang S, Lee H, Jeon KH, Shin DW. Frequent drinking is more predictive of ischemic stroke than binge drinking, but not of myocardial infarction. Atherosclerosis. 2022;350:65–72.
16.
Jeong SM, Yoo JE, Jeon KH, Han K, Lee H, Lee DY, Shin DW. Associations of reproductive factors with incidence of myocardial infarction and ischemic stroke in postmenopausal women: a cohort study. BMC Med. 2023;21:64.
17.
Yeo Y, Jeong SM, Shin DW, Han K, Yoo J, Yoo JE, Lee SP. Changes in alcohol consumption and risk of heart failure: a Nationwide population‐based study in Korea. Int J Environ Res Public Health. 2022;19:16265.
18.
Cho YY, Kim B, Choi D, Kim CH, Shin DW, Kim JS, Park SJ, Kim SW, Chung JH, Han K, et al. Graves' disease, its treatments, and the risk of atrial fibrillation: a Korean population‐based study. Front Endocrinol (Lausanne). 2022;13:1032764.
19.
Khan NF, Perera R, Harper S, Rose PW. Adaptation and validation of the Charlson index for read/OXMIS coded databases. BMC Fam Pract. 2010;11:1.
20.
Yoo JE, Kim M, Kim B, Lee H, Chang WH, Yoo J, Han K, Shin DW. Increased risk of myocardial infarction, heart failure, and atrial fibrillation after spinal cord injury. J Am Coll Cardiol. 2024;83:741–751.
21.
Mao CT, Tsai ML, Wang CY, Wen MS, Hsieh IC, Hung MJ, Wang CH, Chen CC, Chen TH. Outcomes and characteristics of patients undergoing percutaneous angioplasty followed by below‐knee or above‐knee amputation for peripheral artery disease. PLoS One. 2014;9:e111130.
22.
Long CA, Mulder H, Fowkes FGR, Baumgartner I, Berger JS, Katona BG, Mahaffey KW, Norgren L, Blomster JI, Rockhold FW, et al. Incidence and factors associated with major amputation in patients with peripheral artery disease: insights from the EUCLID trial. Circ Cardiovasc Qual Outcomes. 2020;13:e006399.
23.
Eckard CS, Pruziner AL, Sanchez AD, Andrews AM. Metabolic and body composition changes in first year following traumatic amputation. J Rehabil Res Dev. 2015;52:553–562.
24.
Rose HG, Schweitzer P, Charoenkul V, Schwartz E. Cardiovascular disease risk factors in combat veterans after traumatic leg amputations. Arch Phys Med Rehabil. 1987;68:20–23.
25.
Modan M, Peles E, Halkin H, Nitzan H, Azaria M, Gitel S, Dolfin D, Modan B. Increased cardiovascular disease mortality rates in traumatic lower limb amputees. Am J Cardiol. 1998;82:1242–1247.
26.
Peles E, Akselrod S, Goldstein DS, Nitzan H, Azaria M, Almog S, Dolphin D, Halkin H, Modan M. Insulin resistance and autonomic function in traumatic lower limb amputees. Clin Auton Res. 1995;5:279–288.
27.
Naschitz JE, Lenger R. Why traumatic leg amputees are at increased risk for cardiovascular diseases. QJM. 2008;101:251–259.
28.
Nerem RM. Hemodynamics and the vascular endothelium. J Biomech Eng. 1993;115:510–514.
29.
Hanada T, Hashimoto M, Nosaka S, Sasaki T, Nakayama K, Masumura S, Yamauchi M, Tamura K. Shear stress enhances prostacyclin release from endocardial endothelial cells. Life Sci. 2000;66:215–220.
30.
Ballermann BJ, Dardik A, Eng E, Liu A. Shear stress and the endothelium. Kidney Int Suppl. 1998;67:S100–S108.
31.
Pan S. Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress. Antioxid Redox Signal. 2009;11:1669–1682.
32.
Berk BC, Korshunov VA. Genetic determinants of vascular remodelling. Can J Cardiol. 2006;22(suppl B):6B–11B.
33.
Schofield CJ, Libby G, Brennan GM, MacAlpine RR, Morris AD, Leese GP; DARTS/MEMO Collaboration . Mortality and hospitalization in patients after amputation: a comparison between patients with and without diabetes. Diabetes Care. 2006;29:2252–2256.
34.
Perrone‐Filardi P, Paolillo S, Costanzo P, Savarese G, Trimarco B, Bonow RO. The role of metabolic syndrome in heart failure. Eur Heart J. 2015;36:2630–2634.
35.
Ooi H, Chung W, Biolo A. Arterial stiffness and vascular load in heart failure. Congest Heart Fail. 2008;14:31–36.
36.
Marti CN, Gheorghiade M, Kalogeropoulos AP, Georgiopoulou VV, Quyyumi AA, Butler J. Endothelial dysfunction, arterial stiffness, and heart failure. J Am Coll Cardiol. 2012;60:1455–1469.
37.
Weber T, O'Rourke MF, Ammer M, Kvas E, Punzengruber C, Eber B. Arterial stiffness and arterial wave reflections are associated with systolic and diastolic function in patients with normal ejection fraction. Am J Hypertens. 2008;21:1194–1202.
38.
Ikonomidis I, Tzortzis S, Papaioannou T, Protogerou A, Stamatelopoulos K, Papamichael C, Zakopoulos N, Lekakis J. Incremental value of arterial wave reflections in the determination of left ventricular diastolic dysfunction in untreated patients with essential hypertension. J Hum Hypertens. 2008;22:687–698.
39.
Westerhof N, O'Rourke MF. Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens. 1995;13:943–952.
40.
Santillan‐Cortez D, Vera‐Gomez E, Hernandez‐Patricio A, Ruiz‐Hernandez AS, Gutierrez‐Buendia JA, De la Vega‐Moreno K, Rizo‐Garcia YA, Loman‐Zuniga OA, Escotto‐Sanchez I, Rodriguez‐Trejo JM, et al. Endothelial progenitor cells may be related to major amputation after angioplasty in patients with critical limb ischemia. Cells. 2023;12:584.
41.
Everson‐Rose SA, Lewis TT. Psychosocial factors and cardiovascular diseases. Annu Rev Public Health. 2005;26:469–500.
42.
Rosengren A, Hawken S, Ounpuu S, Sliwa K, Zubaid M, Almahmeed WA, Blackett KN, Sitthi‐amorn C, Sato H, Yusuf S. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): case‐control study. Lancet. 2004;364:953–962.
43.
Ranjit N, Diez‐Roux AV, Shea S, Cushman M, Seeman T, Jackson SA, Ni H. Psychosocial factors and inflammation in the multi‐ethnic study of atherosclerosis. Arch Intern Med. 2007;167:174–181.
44.
Festa A, D'Agostino R Jr, Howard G, Mykkänen L, Tracy RP, Haffner SM. Chronic subclinical inflammation as part of the insulin resistance syndrome: the insulin resistance atherosclerosis study (IRAS). Circulation. 2000;102:42–47.
45.
Chen LY, Leening MJ, Norby FL, Roetker NS, Hofman A, Franco OH, Pan W, Polak JF, Witteman JC, Kronmal RA, et al. Carotid intima‐media thickness and arterial stiffness and the risk of atrial fibrillation: the atherosclerosis risk in communities (ARIC) study, multi‐ethnic study of atherosclerosis (MESA), and the Rotterdam study. J Am Heart Assoc. 2016;5:e002907.
46.
Wei J, Li Z, Diao J, Li X, Min L, Jiang W, Yan F. Effect of lower limb amputation level on aortic hemodynamics: a numerical study. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2022;39:67–74.
47.
Garcia MM, Lima JR, Junior JD, Freire HA, Mazilão JD, Vicente EJ. Energy expenditure and cardiovascular response to traumatic lower limb amputees' gait. Fisioterapia Eem Movimento. 2015;28:259–268.
48.
Al‐Mallah MH, Sakr S, Al‐Qunaibet A. Cardiorespiratory fitness and cardiovascular disease prevention: an update. Curr Atheroscler Rep. 2018;20:1.
49.
Jung W, Kim M, Jeon HJ, Chang WH, Yoo JE, Han K, Shin DW. Assessment of disability and depression following amputation among adults in Korea. JAMA Netw Open. 2023;6:e2320873–e2320873.
50.
Cubbin C, Sundquist K, Ahlén H, Johansson SE, Winkleby MA, Sundquist J. Neighborhood deprivation and cardiovascular disease risk factors: protective and harmful effects. Scand J Public Health. 2006;34:228–237.
51.
Ephraim PL, MacKenzie EJ, Wegener ST, Dillingham TR, Pezzin LE. Environmental barriers experienced by amputees: the Craig Hospital inventory of environmental factors‐short form. Arch Phys Med Rehabil. 2006;87:328–333.
52.
Cascini S, Agabiti N, Davoli M, Uccioli L, Meloni M, Giurato L, Marino C, Bargagli AM. Survival and factors predicting mortality after major and minor lower‐extremity amputations among patients with diabetes: a population‐based study using health information systems. BMJ Open Diabetes Res Care. 2020;8:8.
53.
Tentolouris N, Al‐Sabbagh S, Walker MG, Boulton AJ, Jude EB. Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5‐year follow‐up study. Diabetes Care. 2004;27:1598–1604.
54.
Aulivola B, Hile CN, Hamdan AD, Sheahan MG, Veraldi JR, Skillman JJ, Campbell DR, Scovell SD, LoGerfo FW, Pomposelli J, et al. Major lower extremity amputation: outcome of a modern series. Arch Surg. 2004;139:395–399.
Information & Authors
Information
Published In
Copyright
© 2024 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
Versions
You are viewing the most recent version of this article.
History
Received: 26 October 2023
Accepted: 8 April 2024
Published online: 10 May 2024
Published in print: 21 May 2024
Keywords
Subjects
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Increased Risk of End-Stage Kidney Disease After Traumatic Amputation: Nationwide Cohort Study, Healthcare, 13, 1, (80), (2025).https://doi.org/10.3390/healthcare13010080
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.